相关实验视频
Updated: Jun 7, 2025

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.5K
人类循环素的心脏毒性
Elizabeth Balough1, Abul Ariza2, Aarti Asnani3
1Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Baker 4, Boston, MA 02215, USA. Electronic address: https://twitter.com/ElizabethBaloug.
Cardiology clinics
|November 17, 2024
概括
抗环素化疗可以导致心脏损伤 (心脏毒性),主要影响左心室. 通过生物标志物和成像的早期检测,以及风险评估和预防策略,是管理这种风险的关键.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 人环素化疗是一种常见的癌症治疗方法.
- 心脏毒性是 antracyclines 的一个显著的副作用,往往导致左心室缩功能障碍在治疗的第一年内.
- 临床症状可能不会出现,直到发生重大损伤.
研究的目的:
- 强调早期检测环素诱导心脏毒性的重要性.
- 强调在治疗前进行全面的心血管风险评估的必要性.
- 概述预防策略,以减轻心脏毒性.
主要方法:
- 使用生物标志物用于早期检测心脏功能障碍.
- 采用心血管成像技术监测心脏健康.
- 在开始治疗之前进行彻底的心血管风险评估.
主要成果:
- 通过生物标志物和成像,可以通过临床表现之前实现心脏毒性的早期检测.
- 综合风险评估有助于根据患者患心脏毒性发展的可能性对患者进行分层.
- 预防措施显著降低了心脏毒性的发生率和严重程度.
结论:
- 积极的心血管风险评估和管理对于接受 antracycline 化疗的患者至关重要.
- 诸如剂量修改,脂质体配方和德克斯拉佐等心脏保护剂等干预措施可以减轻心脏毒性.
- 长期的随访和持续的风险因素优化对于癌症幸存者来说至关重要,以确保最佳的心血管健康.
相关概念视频
Heart Failure Drugs: Inotropic Agents
523
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
523
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
391
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
391
Myocarditis I: Introduction
2
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Exercise and Cardiovascular Response
739
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
739
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K

